Skip to main content

Immunome Inc S-3ASR, filed Nov 9, 2026

Immunome Inc. (IMNM)

Immunome registered up to approximately $134.1 million of common stock for sale through TD Securities (USA) LLC or TD Cowen, replacing a prior $200.0 million agreement under which it sold 6,655,587 shares for gross proceeds of $65.9 million. AI summary

S-3ASR 2026-11-09
View Original
Added on November 09, 2026